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ObjectiveaaThis study was to investigate the current use of depression rating scales by psychiatrists and clinical psychologists in Korea.
MethodsaaThe questionnaires from many psychiatrists and clinical psychologists were included in the analysis. The questionnaire was com-
posed of items about examining the percentage of patients clinically using depression rating scales, reasons for not use of them, the degree 
of satisfaction, the perceived agreement rate between the result of depression rating scales and doctor’s clinical interview in the evaluation 
of patients with depressive symptoms. Data were analyzed by χ2 and independent t-test. 
ResultsaaThe clinical use of depression rating scales was more frequent in the psychologists than in the psychiatrists. The purposes for 
using depression rating scales were assessed into six areas, there was no significant difference in between two groups, and both groups po-
inted out their purpose as rating of severity and screening. The reasons for not using scales were that their interview may be sufficient for 
diagnosis and assessment of depressive patients and they are not familiar with the use of depression rating scales. The psychiatrists usually 
prefer the Beck Depression Inventory (BDI), Hamilton Depression Rating Scale and Symptom Checklist 90-Revision (SCL-90-R) in order 
of frequency, and the clinical psychologists are more likely to use the BDI, Minnesota Multiphasic Personality Inventory and SCL-90-R. 
Overall rate of satisfaction in the use of the scales was 67.29±14.45% and overall perceived agreement rate was 70.89±16.45%.
ConclusionaaCurrently used depression rating scales at the clinical practice were not various. Therefore, to heighten clinicians’ utility 
of these depression rating scales measures, either educational efforts or advertisements, or both, will be necessary to spread them wildly.
  Psychiatry Investig 2010;7:170-176
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INTRODUCTION 
Depression is a common psychiatric problem, so one out of 
ten experiences it one or more times for a whole life and the 
probability of having it for a whole life reaches to 30%.
1 How-
ever, it is also a very serious disease because 10-15% of patients 
with depression can show fatal outcomes such as suicide. Ac-
cording to ‘Global Burden of Disease Study’ funded by World 
Health Organization, depression ranked the fourth among 
total diseases by accounting for 3.7% of the total disability-
adjusted life-years (DALY) in 1990 and it was expected to 
become the second by recording 5.7% of the total DALY in 
2020.
2 According to study of cross-national epidemiology of 
major depression, the lifetime prevalence for major depres-
sion vary widely across countries, ranging from 1.5 percent in 
Taiwan and 2.9 percent in Korea to 19.0 percent in Beirut. In 
every country, the rates of major depression were higher for 
women than men.
3 An epidemiological survey conducted 2009 
in Korea also that lifetime prevalence of major depressive dis-
orders was 5.6% and lifetime prevalence according to gender 
showed higher for women than men as 3.6% in males and 7.6% 
in females.
4 However, cultural differences or different risk 
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factors affect the expression of the disorder
3 and the definition 
of depression or measures for assessing a prevalence of depres-
sion is different as studies.
4,5 When if existing studies of prev-
alence considered above factors, the total prevalence of de-
pression is considered to be higher in clinical practice.
5 There-
fore, there has been increasing interest to the depression rating 
scales for objective measure and easy use as well as for early 
diagnosis, differential diagnosis, and assessment of severity 
of depressive disorders.
6-8 
Rating scales are a research tool that can systematically ver-
ify the hypotheses of clinical judgment, decision making, and 
psychopathology, as well as a measurement tool that trans-
forms the implicit and explicit observation into quantitative 
data.
8 So far there are 16 clinician-rated and self-rated inven-
tories for depression standardized in Korea, such as Beck De-
pression Inventory (BDI),
9 BDI-II,
10 Zung’s Self-Rating Depres-
sion Scale,
9-11 Minnesota Multiphasic Personality Inventory 
(MMPI),
12 Symptom Checklist 90-Revision (SCL-90-R),
13 Pa-
tient Health Questionnaire (PHQ-9),
14 Geriatric Depression 
Scale
15,16 and Children Depression Inventory.
17,18 Most of them, 
however, were translated and standardized with the original 
scales developed in other countries. The only depression rat-
ing scale developed in Korea is ‘Korean Depression Scale’ of 
Lee and Rhee.
19 Purposes of using these scales vary from de-
termining severity of symptoms to differentiating various di-
agnoses of mental disorders and to observing the degree of im-
provement after treatments.
10 The types of scales are different 
according to what is measured. 
To determine the impact of treatment in mental health clin-
ical setting, it is necessary to evaluate the treatment outcome. 
While governmental policy statements on mental health prac-
tice over the past decade have emphasized individual patient’s 
outcome, little is known about the actual use of standardized 
outcome measures by clinicians.
20 Current domestic situation 
is emphasized to use objective measures such as BDI, Rating 
Scale for Depression (HRDS) which evaluate treatment out-
come and severity of depressive symptoms, and so it is a global 
trend for clinicians to encourage a use of depression rating 
scales.
10,20 Gilbody et al.
22 surveyed 340 psychiatrists in the Un-
ited Kingdom regarding their use of outcome measures. Only 
10.5% and 11.2% of the psychiatrists routinely used standard-
ized measures to assess severity and outcome when treating 
depression and anxiety disorders. More than half of the clini-
cians represented that they never used standardized measures 
to evaluate outcome. The most commonly used measures 
were BDI, Hospital Anxiety Depression Scale (HADS),
36 HDRS. 
Recently, Zmimerman and McGlinchey
7 also surveyed to 
determine how frequently psychiatrists used scales to mea-
sure outcome when treating depressed patients and, to ascer-
tain the reasons for the lack of use for those clinicians who 
do not regularly use such scales. The majority of psychiatrists 
indicated that they never or rarely used scales to monitor 
outcome, and less than 10% almost always used scales to 
monitor outcome of depression treatment. The reasons for not 
routinely using scales in their clinical practice indicated be-
cause clinicians did not believe using scales would be helpful, 
the scales take too much time to use, and they were not trained in 
their use. 
As above mentioned, there were used to be standardized in 
Korea for many depression rating scales developed in other 
countries, alike depression rating scales developed in Korea 
is using. However, little is systematic survey or study for what 
degree might be current use with mental health specialists 
working in clinical. Therefore, this study was to investigate 
the current use of depression measures in clinical setting in 
Korea. Namely the goals of the present study were to investi-
gate the frequency and reason of not using, the degree of per-
ceived satisfaction of currently available depression rating 
scales, and the perceived agreement between subjective clini-
cal interviews and depressive measures. We hope this investi-
gation is a basic research for inventing Korean standardized 
diagnosis and rating scales for depression in the future. 
METHODS
Subjects
This study was conducted from July to September, 2006 and 
the questionnaire was distributed to psychiatrists and mental 
health clinical psychologists by mail. Participants in this study 
were psychiatrists working at university hospitals, general 
hospitals, mental hospitals, and private practices. Some psy-
chiatrists involved in one of the national research projects for 
depression, ‘Clinical Research Center for Depression.’ Clini-
cal psychologists were working at university hospitals, gener-
al hospitals, mental hospitals, mental health centers, counsel-
ing clinics, and research institutes. The questionnaires were 
distributed to totally 208 psychiatrists and 60 clinical psycholo-
gists by mail. 123 (59.1%) of psychiatrists and 50 (83.3%) of 
clinical psychologists were replied to our center. So, the total 
return rate was 64.9%. Finally, 123 psychiatrists and 50 clini-
cal psychologists were included in this study by excluding in-
complete answers. Demographic data of the total subjects fill-
ing in the questionnaires were shown in Table 1. 
Questionnaire
Working committee was organized and composed of four 
psychiatrists, two clinical psychologists and one medical stat-
istician to make a draft of the questionnaire after reviewing 
depression rating scales used in Korea. This committee had 
several revisions of questionnaire for making an appropriate 172  Psychiatry Investig 2010;7:170-176
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question and amount of it through many meetings. 
The questionnaire consisted of total 6 items. The first item 
of questionnaire elicited subjects’ demographic characteris-
tics (age, sex) and professional background (working region, 
working setting, years after a license). The second item of the 
questionnaire included 5 questions. The first question was “how 
often do you use depression rating scales for patients com-
plainting of depressive symptoms” and “how often do you use 
depression rating scales for patients complainting of ones 
mainly other than those symptoms”. The visual analog scores 
ranging from 0 to 100 percent was used to assess. The second 
question was “What do you do purpose using a rating scale?”. 
This question was only checked in clinicians answered ‘yes’ 
(psychiatry 54.5%, clinical psychologists 88%), which use de-
pression rating scales for patients. Subjects were asked to 
choose one of next six items; 1) screening 2) diagnosis 3) dif-
ferentiated diagnosis 4) severity 5) determination of treatment 
effect and observation of symptom changes 6) other. The third 
question was “Why you do not use scales in clinical practice”. 
Subjects were asked to choose one of next five items; 1) I can 
do sufficiently diagnosis and assessment by only psychiatric 
interview 2) I am not familiar with use of rating scales 3) I 
can’t believe reliability and validity of rating scales 4) I don’t 
want to be any more economic burden to patients 5) other. 
To next question, subjects were asked to check visual analog 
scale to assess the subjective degree of satisfaction after use of 
rating scales and the perceived level of agreement between 
subjective interview of psychiatrists and results of rating 
scale. The fifth item was “Please indicate three in order what 
do you do kinds of most frequently using rating scales among 
25 domestic and foreign depression rating scales including 
standardized and non-standardized ones in Korea”. If it is be-
low 50%, they were asked to directly describe why they do 
not use scales in clinical practice.
Data analysis
Data were analyzed with Statistical Package for the Social 
Sciences Win. Ver. 14.0 (SPSS Inc., Chicago, IL, USA) and sig-
nificance level was 0.05. Mean, standard deviation and inde-
pendent t-test were used for quantitative data and frequency, 
percent and χ2-test were utilized for qualitative data.
RESULTS 
Current use of depression rating scales
When a patient was examined medically with chief com-
plaints of depression symptoms and other ones except de-
pression, the frequency of using depression rating scales was 
significantly different between psychiatrists and clinical psy-
chologists (p<0.001) and the average rate of clinical psycholo-
gists was higher than that of psychiatrists. Totally, in about 
70% of cases with depression symptoms and around 44% of 
cases with other symptoms except depression, depression rat-
ing scales were used. A purpose of use to rating scales in med-
Table 1. Demographic data for all survey responders
Psychiatrist Clinical psychologist All
N (%)  N (%)  N (%) 
Sex Male 107 (87.0) 17 (34.0) 124 (71.7)
Female 16 (13.0) 33 (66.0)  49 (28.3)
Age 42.0 (8.9)0 31.9 (6.7)0 39.1 (9.5)0
Working region Seoul, Gyeonggido 16 (13.0) 9 (18.0) 25 (14.4)
Daegu, Gyeongbuk 85 (69.1) 39 (78.0) 124 (71.3)
Jeollado 22 (17.9) 2 (4.0)0 24 (13.8)
Working setting University hospital 56 (45.5) 17 (34.0) 73 (42.0)
General hospital 17 (13.8) 3 (6.0)0 20 (11.5)
Mental hospital 26 (21.1) 7 (14.0) 33 (19.0)
Individual hospital 22 (17.9) 4 (8.0)0 26 (14.9)
Centers and research institute 0 (0.0)0 15 (30.0) 15 (8.6)0
Other 2 (1.6)0 4 (8.0)0 6 (3.4)0
Years after a license Under 5 years 34 (27.6) 36 (72.0) 70 (40.2)
Under 5-10 years 32 (26.0) 10 (20.0) 42 (24.1)
Under 10-15 years 18 (14.6) 3 (6.0)0 21 (12.1)
Under 15-20 years 12 (9.8)0 1 (2.0)0 13 (7.5)0
Over 20 years 27 (22.0) 0 (0.0)0 27 (15.5)EJ Lee et al. 
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ical examination of depression patients was investigated and 
there was no statistically significant difference between the 
two groups (Table 2). 
Subjects who reported using below 50% ware asked the 
reasons for not using scales in clinical practice. More than 60% 
of psychiatrists was indicated that they did sufficient diagno-
sis and assessment by only psychiatric interview, about 19.6% 
that did not familiar with use of rating scales, while 80% of 
clinical psychiatrists did other (Table 3).
Agreement and satisfaction between subjective 
interviews and results of depression rating scales
The perceived level of agreement between subjective inter-
views and results of depression rating scales was found to be 
about 70% overall, psychiatrists and clinical psychologists 
did not show any significant difference in it (Table 4). For the 
cases in which the agreement was less than 50%, reasons for 
that was analyzed qualitatively and answers such as ‘results of 
the scales are exaggerated or underestimated compared to an 
actual condition’, ‘the scales focus on subjective symptoms’, 
‘questions and expression of the scales are vague’ and ‘children 
do not recognize themselves well’ were observed. 
Overall, the subjective degree of satisfaction at depression 
rating scales was 67% and there was no significant difference 
between the two groups (Table 4). For the cases showing less 
than 50% satisfaction, reasons including ‘various patterns of 
depression exist’, ‘there is difference between subjective com-
plaints and results of an interview in medical examination’, ‘di-
agnostic usefulness is poor’, ‘severity is not reflected accurate-
ly’ and ‘patients refuse to answer some of questions (ex. sexual 
contents)’ were pointed out. 
Kinds of use of depression rating scale 
Among currently used rating scales, the most commonly 
Table 2. Rate and purpose of use of depression rating scales
Psychiatrist Clinical psychologist All
t (p)
Mean (SD)
Rate of use
Patient complainting of depressive symptoms  59.96 (28.50) 84.77 (24.78) 69.79 (29.60) −4.72 (0.000)
Patient complainting of mainly other than depressive symptoms 32.78 (25.75) 62.05 (31.74) 44.38 (31.60) −5.34 (0.000)
Purpose of use N (%) χ2 (p)
Screening 13 (19.4)0 14 (31.8)0 27 (24.3)0
9.94 (0.077)
Diagnosis 8 (11.9)0 10 (22.7)0 18 (16.2)0
Differentiated diagnosis 2 (3.0)00 1 (2.3)00 3 (2.7)00
Severity 25 (37.3)0 16 (36.4)0 41 (36.9)0
Treatment effect judgement and processing observation 18 (26.9)0 3 (6.8)00 21 (18.9)0
Other 1 (1.5)00 0 (0.0)00 1 (0.9)00
SD: standard deviation
Table 3. Reason for not using depression rating scales
Psychiatrist Clinical psychologist All
χ2 (p)
N (%)
I can do sufficiently diagnosis and assessment in only psychiatric interview 38 (67.9) 1 (20.0) 39 (63.9)
30.33 (0.000)
I am not familiar with use of rating scales 11 (19.6) 0 (0.0)0 11 (18.0)
I can’t believe reliability and validity of rating scales 3 (5.4) 0 (0.0)0 3 (4.9)
I don’t want to be any more economic burden to patients 2 (3.6) 0 (0.0)0 2 (3.3)
Other 2 (3.6) 4 (80.0) 6 (9.8)
Table 4. Agreement rate between interview and the results of rating scale for depressive patients, a general satisfaction after use of depres-
sion rating scales
Psychiatrist Clinical psychologist All
t (p)
Mean (SD)
Agreement 71.68 (12.93)  69.71 (20.79) 70.89 (16.45) 0.57 (0.573)
Satisfaction 68.35 (13.84) 65.57 (16.32) 67.26 (14.85) 0.97 (0.335) 
SD: standard deviation174  Psychiatry Investig 2010;7:170-176
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used scales for depression patients was BDI (68.9%), HRSD 
(30.5%) and SCL-90-R (18.9%) in the order for psychiatrists 
while BDI (57.4%) was most frequently used, followed by 
MMPI (37.0%) and SCL-90-R (31.1%) for clinical psycholo-
gists. Psychiatrists and clinical psychologists showed a signifi-
cant difference in the first and the second ranks (p<0.001) but 
there was no significant difference in the third rank. Both of the 
two groups responded that reasons for not using scales not 
ranking the first, the second and the third were unfamiliarity, 
unsecured reliability and validity, lack of information on 
them and a long time for scoring them. 
DISCUSSION
With psychiatrists and clinical psychologists working at 
the clinical field as subjects this study surveyed frequency of 
use, depression measures, the subjective degree of satisfaction 
and the perceived level of agreement between subjective cli-
nicians judgment and rating scales. Such a study was per-
formed first in the domestic clinical field and it was consid-
ered to be a basic research for development of Korean stan-
dardized depression diagnosis and rating scales in future. 
Similar to the results of the survey conducted by Gilbody et 
al.,
22 Zimmerman and McGlinchey,
7 our results indicated that 
psychiatrists are not using depression rating sales to evaluate 
patients complainting of depressive symptoms. Also, our re-
sults showed that the clinical use of depression rating scales 
is more frequent in the clinical psychologists than in that of psy-
chiatrists regardless of whether depressive symptoms or not. 
This result could be considered to reflect that two groups are 
clearly different in professional role in clinical practices. Al-
though clinical psychologist’s main work is to assessing pa-
tients, it is remarkable that most psychiatrists are not generally 
using quantified measures to evaluate outcome when treat-
ing depression patients. To those, foreign studies suggested that 
psychiatrists did not believe that the regular use of scales would 
be clinically helpful, and that scales would take too much time 
to administer and they have a lack of previous training.
7 Simi-
larly, our surveys indicated that they were able to diagnosis 
and assessment by only subjective psychiatric interview and 
that did not familiar with use of rating scales. Like Zimmer-
man and McGlinchey,
7 we suspect that psychiatrists were con-
sidering clinician rating scales such as the Hamilton Rating 
Scale for Depression
21 when answering why they did not use sc-
ales and were not believing depression rating scales to be re-
liable, valid measures. As the most helpful advantages of the 
depression rating scales both of psychiatrists and clinical psy-
chologists pointed out rating of severity and screening, so one 
of main purposes of the scales could be said to be screening. 
As results of self-rated inventories such as BDI
9 and those of 
a structured interview like Schedule for Affective Disorders 
and Schizophrenia
23 were found to be similar to a certain de-
gree, the depression rating scales such as BDI have been used 
widely as a method to screen a group with high possibility of 
depression.
10,23-25 Also, there were the advantage of self-report 
questionnaires, which require little training and do not take 
much clinician time to administer and score.
Among domestic and foreign depression rating scales in-
cluding standardized and non-standardized ones in Korea, 
the types of depression rating scales currently used in clinical 
practices field were observed not to be various. Psychiatrists 
used frequently BDI, HRSD and SCL-90-R in the order and 
clinical psychologists did BDI, MMPI and SCL-90-R in the 
order. Similar to results of the survey of psychiatrists practis-
ing conducted in the UK by Gilbody et al.
22 indicated that the 
most commonly used measures were BDI, HADS, HRSD for 
identifying and assessing the severity and measuring clinical 
change over time of depression and anxiety problems. As 
above mentioned depression rating scales such as BDI, HRSD, 
SCL-90-R, MMPI have been known as proper scales from 
determining severity of symptoms to diagnosing the possi-
bility of depression and to observing the degree of improve-
ment after treatments.
6-10,23-25 The types of scales could differ-
ent according to what is measured, also there were a advantage 
and a shortcoming in each scales. Namely there were the ad-
vantage of self-rating scales, which require little training and 
do not take much clinician time to administer and score, but 
there were not used to diagnosis depression. However, the 
clinician rating scales such as HRSD had the shortcoming in 
aspect of time and cost as administer systematically training 
clinicians, but was able to assess more objectively and exactly 
symptoms and severity.
10.23-25 Also, we suspect that the differ-
ence between the two groups was considered to result from 
acquaintance with only these scales during the training peri-
od of psychiatrists and clinical psychologists. Moreover, al-
though total 25 depression rating scales including standard-
ized and non-standardized ones were presented, both of the 
two groups chose only several scales as currently used ones. 
Both of the two groups responded that reasons for not using 
scales not ranking the first, the second and the third were un-
familiarity, unsecured reliability and validity, lack of informa-
tion on them and a long time for scoring them. These results 
were similar with those of Gilbody et al.
22 and Zimmerman 
and McGlinchey.
7 reporting that the use of previous scales 
were avoided because their reliability and validity were 
doubted, an economic burden was much and using them 
usually every time was annoying. To deal with these prob-
lems simple scales with a small number of questions which 
validity and reliability were already proven were developed 
and used and they included Clinically Useful Depression EJ Lee et al. 
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Outcome Scale (CUDOS),
26 The 16-item Quick Inventory of 
Depressive Symptomatology,
27 Patient Health Questionnaire-2 
(PHQ-2)
28,29 and PHQ-9.
14 Among them validity and reliabil-
ity of CUDOS
33 were verified and PHQ-9
34 were in the pro-
cess of being verified. In addition, a study on validity and re-
liability of Psychiatric Diagnostic Screening Questionnaire,
30 
which is a self-rated inventory meeting DSM-IV
35 diagnosis 
standards and can be utilized usefully, was also being con-
ducted and it was expected to be a very useful scale in outpa-
tient clinics considering the environment of Korean clinical 
field in which doctors should examine many patients for a 
short time. 
The perceived level of agreement between results of de-
pression rating scales and those of subjective clinical inter-
views, the degree of satisfaction after using the scales were no 
significant difference between the two groups. And they were 
tended to be high by recording about 70% in the two groups. 
However, subjects answering that the level of agreement was 
less than 50% were pointed out exaggerated or underestimat-
ed rating, subjective complaints, vague questions and expres-
sion and limitation for specific subjects (ex. children) as the 
reasons for lower agreement. These responses reflected limi-
tations of self-rated inventories well and many researchers had 
referred to them.
27 In other words, although self-rated inven-
tories were widely used as one of the most general methods 
among psychological measurements, their results could be 
affected by a tendency of showing a socially desirable attitude 
and they could obtain unreliable data from young children at 
a cognitively premature development stage. In addition, rea-
sons for less than 50% of satisfaction at the scales were report-
ed to be diversity of depression patterns, disagreement among 
results of tests, inaccuracy of severity rating and no response, 
and they presented limitations of previous scales well. Like 
the result of survey, it was alike those of previous researches 
saying that children also showed depression including emo-
tional, cognitive, motive, physical and psycho-motor symp-
toms like adults and specific clinical characteristics could be 
found according to ages.
31,32 Therefore, this result suggested 
again urgency of development of scales screening well vari-
ous clinical patterns of basically special groups and reflecting 
cultural characteristics and values. 
In conclusion, as the rate of use of depression rating scales 
of clinical psychologists was higher than that of psychiatrists, 
difference in roles of the two groups could be observed clear-
ly. In addition, currently used depression rating scales at the 
clinical field were not various. While agreement and satisfac-
tion were found to be positive overall among the subjects of 
this study, subjects avoiding using them actually showed a 
negative response. The reasons for the negative evaluation were 
various clinical patterns according to gender and age, prob-
lems related to reliability and validity of the scales, specialty 
according to development stages, unfamiliarity and lack of in-
formation on them, and they reflected problems of existing 
scales. This result is thought to exaggerate necessity of devel-
opment of depression rating scales more, and development 
of scale handling with problems of existing scales and being 
useful for a limited environment of outpatient clinics where 
doctors should see many patients for a short time may urgent. 
However, some scales supplementing the limitations of exist-
ing scales mentioned above were already developed, verified 
and used for academic and clinical purposes. Among them 
several ones’ validity and reliability were also proven in Korea. 
Like this, the reason why they were already invented but were 
not widely used was considered to be lack of education and 
advertisement for them. Rather than only trying to invent do-
mestic rating scales, standardization of scales developed and 
verified in foreign countries also should be considered to se-
cure variety and usefulness of depression rating scales. 
Lastly, this study had following limitations. This study re-
cruited subjects only working at the clinical field. But, if sub-
jects of this study had included ones with licenses not work-
ing at the field to reflect their opinion, a more accurate survey 
on current situation would have been possible because there 
may be a difference between kinds and purpose of use of scales 
demanding at nonclinical practice and clinical one. In addi-
tion, the subjects were not various according to regions be-
cause a considerable data was lost in the process of sending 
and collecting questionnaires by mail and clinical psycholo-
gists in other regions except the region of researchers were 
hard to be recruited. That showed indirectly that there was de-
viation in distribution of them according to regions and their 
number was also limited. 
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